These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25856039)

  • 21. Improving surveillance and quality of life of BRCA mutation carriers.
    Loman N; Borg A
    J Clin Oncol; 2010 Aug; 28(22):e376-7. PubMed ID: 20458044
    [No Abstract]   [Full Text] [Related]  

  • 22. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
    Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA
    J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.
    Vencken PM; Kriege M; Hooning M; Menke-Pluymers MB; Heemskerk-Gerritsen BA; van Doorn LC; Collée MM; Jager A; van Montfort C; Burger CW; Seynaeve C
    Cancer; 2013 Mar; 119(5):955-62. PubMed ID: 23165859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining crucial correlates of breast self-examination in older women with low incomes.
    Morrison C
    Oncol Nurs Forum; 1996; 23(1):83-93. PubMed ID: 8628714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health beliefs related to breast self-examination in a sample of Turkish women.
    Nahcivan NO; Secginli S
    Oncol Nurs Forum; 2007 Mar; 34(2):425-32. PubMed ID: 17573306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.
    Andrieu N; Easton DF; Chang-Claude J; Rookus MA; Brohet R; Cardis E; Antoniou AC; Wagner T; Simard J; Evans G; Peock S; Fricker JP; Nogues C; Van't Veer L; Van Leeuwen FE; Goldgar DE
    J Clin Oncol; 2006 Jul; 24(21):3361-6. PubMed ID: 16801631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
    Metcalfe KA; Poll A; Llacuachaqui M; Nanda S; Tulman A; Mian N; Sun P; Narod SA
    Clin Genet; 2010 Nov; 78(5):411-7. PubMed ID: 20653694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.
    Catucci I; Verderio P; Pizzamiglio S; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Ripamonti CB; Pasini B; Barile M; Viel A; Giannini G; Papi L; Varesco L; Martayan A; Riboni M; Volorio S; Radice P; Peterlongo P
    Breast Cancer Res Treat; 2011 Feb; 125(3):855-60. PubMed ID: 20652397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
    Rennert G; Bisland-Naggan S; Barnett-Griness O; Bar-Joseph N; Zhang S; Rennert HS; Narod SA
    N Engl J Med; 2007 Jul; 357(2):115-23. PubMed ID: 17625123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peer support and additional information in group medical consultations (GMCs) for BRCA1/2 mutation carriers: A randomized controlled trial.
    Visser A; van Laarhoven HW; Woldringh GH; Hoogerbrugge N; Prins JB
    Acta Oncol; 2016; 55(2):178-87. PubMed ID: 26114234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic predisposition to radiation induced sarcoma: possible role for BRCA and p53 mutations.
    Kadouri L; Sagi M; Goldberg Y; Lerer I; Hamburger T; Peretz T
    Breast Cancer Res Treat; 2013 Jul; 140(1):207-11. PubMed ID: 23824362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation Carriers.
    Fakkert IE; Mourits MJ; Jansen L; van der Kolk DM; Meijer K; Oosterwijk JC; van der Vegt B; Greuter MJ; de Bock GH
    Cancer Prev Res (Phila); 2012 Nov; 5(11):1291-7. PubMed ID: 23009828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
    Kirova YM; Stoppa-Lyonnet D; Savignoni A; Sigal-Zafrani B; Fabre N; Fourquet A;
    Eur J Cancer; 2005 Oct; 41(15):2304-11. PubMed ID: 16140006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA).
    Chenevix-Trench G; Milne RL; Antoniou AC; Couch FJ; Easton DF; Goldgar DE;
    Breast Cancer Res; 2007; 9(2):104. PubMed ID: 17466083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Kotsopoulos J; Lubinski J; Lynch HT; Klijn J; Ghadirian P; Neuhausen SL; Kim-Sing C; Foulkes WD; Moller P; Isaacs C; Domchek S; Randall S; Offit K; Tung N; Ainsworth P; Gershoni-Baruch R; Eisen A; Daly M; Karlan B; Saal HM; Couch F; Pasini B; Wagner T; Friedman E; Rennert G; Eng C; Weitzel J; Sun P; Narod SA; ; Garber J; Osborne M; Fishman D; McLennan J; McKinnon W; Merajver S; Olsson H; Provencher D; Pasche B; Evans G; Meschino WS; Lemire E; Chudley A; Rayson D; Bellati C
    Breast Cancer Res Treat; 2007 Oct; 105(2):221-8. PubMed ID: 17245541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast self-examination proficiency and training effects: women at increased risk of breast cancer.
    Stefanek ME; Wilcox P; Huelskamp AM
    Cancer Epidemiol Biomarkers Prev; 1992; 1(7):591-6. PubMed ID: 1302572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage of breast cancers found during the surveillance of women with a familial or hereditary risk.
    Kaas R; Muller SH; Hart AA; Rutgers EJ
    Eur J Surg Oncol; 2008 May; 34(5):501-7. PubMed ID: 17555911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the general practice program of women education for breast self-examination.
    Katić M; Lang S; Budak A
    Acta Med Croatica; 1996; 50(4-5):185-91. PubMed ID: 9046116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.